Shanghai Lishan Biomedical Co., Ltd.

Shanghai Lishan Biomedical Co., Ltd. was established in 2022, with its headquarters in Pudong, Shanghai, and its live biotherapeutic product R&D center located in Zhangjiang Pharma Valley. Lishan started with the core concept of alleviating suffering, aiming ultimately to reduce the pain of all beings. Since its inception, Lishan has shouldered the mission of safeguarding human health for the benefit of all lives. Our unwavering belief is the vision of reaching the pinnacle of success without leaving any stone unturned. Illuminating ideals under the stars and moon, Lishan people have always focused on human well-being and deeply insight into the suffering of the world. In May 2023, the company jointly established the Intelligent Microbiome Joint Laboratory with Fudan University, and possesses the "Keyin" AI drug discovery and validation platform, ensuring precise and rapid support for every step of drug development. The times present unique opportunities, placing Lishan at the forefront of microbiological science, while also endowing a special mission that urges it to persist unremittingly, refine continuously, embrace innovation, and keep pace with the times. With the value of keen insight into details and the pursuit of excellence, Lishan people are dedicated to developing live biotherapeutic products to promote the common values of humanity, facilitate the elimination of more diseases, and thus realize its valuable dream. Gathering outstanding talents is the source of Lishan's enduring vitality; we are always on the path of discovering talent, continuously amassing true knowledge, and scientific achievements flourish like lush grass. We look forward to the discovery of more unknown microorganisms, expect more miracles to be created through exploration, and rely on customer re-evaluation and their experiential value to better safeguard human health.